DIATOMIC Launches its Final Call to Distribute up to €200K Equity-Free Funding

In its second and final open call for application experiments, DIATOMIC is offering a total of €1.610.000 equity-free funding plus acceleration services to the best startups/ SMEs and Competence Centers across the European microelectronics industry.

DIATOMIC, an exclusive network of Digital Innovation Hubs - set under the EC's Smart Anything Everywhere Initiative, aims to accelerate solutions that apply electronic components, sensors, smart objects and systems across health, agrifood and manufacturing sectors. With this in mind, DIATOMIC offers a 9 - 15 months acceleration programme, and will distribute up to €1.610.000 equity-free funding, with selected consortia receiving up to €200,000 per application experiment.

Eligibility

  • We are only looking for small consortia of a maximum of 3 partners from the EU and H2020 associated countries;
  • Your consortium must include technology providers in the areas of advanced microelectronics & smart systems integration (i.e. Centers of Competence), as well as tech adopters/ users, namely: startups/ SMEs active in health, agrifood, manufacturing;
  • The consortia is to be led by industrial partners - SMEs & midcaps. DIATOMIC also provides assistance in partner search/ matchmaking;
  • Your solution needs to demonstrate clear value to the European economy and society. The minimum TRL required at time of proposal submission should be at the level 3, aiming towards the digitization of products/processes.

The Offer

Top consortiaselected after the closing date on 31stJanuary, 2019, will take part in an intensive, milestone-driven acceleration programme, designed around 3-stages, each of which is a step closer to market entry: 'Design', 'Develop', 'Market'.

Some high-level benefits include:

  • up to €200K equity-free funding per application experiment;
  • personalized technical and business development support;
  • novel testbed and experimentation facilities;
  • awareness-raising, matchmaking, networking activities;
  • access to investment opportunities;

How to Apply?

The deadline for applications - to be submitted at f6s.com/diatomic-opencall2 - is 31 January 2019. For tips and resources on the application process, check out diatomic.eu. For questions, or to request partner search/ matchmaking support, get in touch: f6s.com/diatomic.

About DIATOMIC

DIATOMIC is a network of Digital Innovation Hubs funded under the European Smart Anything Everywhere Initiative. Eight consortia have already been selected for funding and acceleration in the first DIATOMIC Open Call. Each of the top consortia is expected to create significant value resulting from new microelectronics-enabled products, processes, and business models. The second (and final)call for application experimentscloses on 31stJanuary 2019.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 761809.

Most Popular Now

Early Warning System for Intensive Care …

Life-threatening situations occur time and again in an intensive care unit. To make sure that doctors can intervene in time, a team at the German Heart Center Berlin (DHZB) has...

Philips Partners with Orbita to Develop …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Orbita Inc., an innovative provider of conversational artificial intelligence (AI) solutions for healthcare, announced a partnership agreement...

CliniSys Group Creates Single Brand for …

CliniSys Group has created a single brand for its businesses in the UK and Europe, with a refreshed logo and a new website. The move creates a unified identity for CliniSys...

East Lancashire Signs Deal for Early War…

Thousands of NHS professionals across five hospitals in East Lancashire are to benefit from early warning technology that will help them detect and swiftly respond to deteriorating patients in need...

FDA Grants Oxehealth Vital Signs De Novo…

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product, which is incorporated into Oxevision, the...

Telemedicine Improves Access to High-Qua…

The American Academy of Sleep Medicine recently published an update on the use of telemedicine for the diagnosis and treatment of sleep disorders to reflect lessons learned from the transition...

Philips and NHS Implement the First Regi…

Royal Philips (NYSE: PHG, AEX: PHIA), announced it has supported the NHS' Cheshire and Merseyside consortium [1] to become the first regional hub supplying the United Kingdom's National COVID-19 Chest...

AI could Crack the Language of Cancer an…

Powerful algorithms used by Netflix, Amazon and Facebook can 'predict' the biological language of cancer and neurodegenerative diseases like Alzheimer's, scientists have found.

DMEA 2021: Digital Health. 100 % Virtual…

7 - 11 June 2021, Berlin, Germany. An entire week dominated by digital healthcare! With that in mind, early in June DMEA 2021 will be kicking off with a wide range...

X-Rays Combined with AI Offer Fast Diagn…

X-rays, first used clinically in the late 1890s, could be a leading-edge diagnostic tool for COVID-19 patients with the help of artificial intelligence, according to a team of researchers in...

Predicting COVID-19 Outbreaks with Cell …

Mobility tracking using cell phone data showing greater movement of people is a strong predictor of increased rates of COVID-19, according to new data in CMAJ (Canadian Medical Association Journal).